A clean beverage pilot with the lowest formulation and labeling complexity.
Best route for first capital in, first cans out.NOUNS COLA / FUNDABLE BRIEF
Classic cola first. Adaptogen lane second.
The clean pitch is not a miracle tonic. It is a legible beverage pilot with public economics, clear gates, and a reserved functional branch that only advances when the evidence, labeling, and safety work can support it.
THESISclassic first
R&Dadaptogen gated
CAPITAL$120k target
CLAIMSconservative
SURFACEPointCast
WHY THIS WORKS
Fund the thing that can ship without hand-waving.
Investors, sponsors, and collaborators can underwrite a classic cola pilot because the sensory target, cost stack, and route to shelf are easy to explain. Adaptogens stay in the document as upside, but not as the core dependency for the first run.
Ashwagandha-led functional lane for stress-support positioning, if counsel and formulation review clear it.
Most evidence-backed adaptogen path, but still not a casual launch claim.Rhodiola or Panax ginseng daytime lane aimed at fatigue and resilience.
Interesting, but evidence and formulation risk are not as clean for the opening round.EFFECTS / EVIDENCE
Keep the formulations honest.
The evidence does not support spraying every adaptogen buzzword onto a can. The best-supported path is stress-support positioning with ashwagandha, and even that lane needs careful safety and label work.
Ashwagandha · stress / sleep support best-supported adaptogen lane
Rhodiola rosea · fatigue / focus mixed evidence
Panax ginseng · vitality / fatigue modest evidence
Main rule effects are R&D, not free claims
CAPITAL PLAN
Put most of the money under the pilot, not the story.
The adaptation here is simple: reserve a real but modest amount for formula research, and keep the majority of capital focused on the run everyone already understands.
USES OF CAPITAL
Classic cola pilot $96k formula, run deposit, inventory, freight, compliance
Adaptogen R&D reserve $12k formulator work, ingredient review, sample rounds, label draft
PointCast launch media $12k sampling, updates, sponsor credits, conversion surfaces
PUBLISHABLE RULES
- Raise against the pilot everyone can understand.
- Keep adaptogen claims conservative until counsel and labeling review are complete.
- Use PointCast to show gates, proofs, and receipts in public.
- Do not frame preorders or sponsor crates as financial upside.
This is still planning and product strategy, not an investment offering. Food, supplement, label, and marketing claims all need qualified review before sale.
GO TEAM
Now the project sounds like a pilot, not a mood board.
- Formulatorprove base cola, then test functional branch
- Counselclear claims, labels, and ingredient risk
- Fundraisersell the pilot and the gates, not fantasy upside
- PointCastpublish evidence, receipts, and next moves
CASE STUDY
The journey to a Nouns beverage.
A new PointCast case study tracks how AI generation moved Nouns Cola from prompt to board to campaign system to a more fundable product story, and where human judgment still had to take over.
